Suppliers / Shijiazhuang Cready Pharmaceutical R And D

Shijiazhuang Cready Pharmaceutical R And D

China Updated 9 July 2026

Shijiazhuang Cready Pharmaceutical R And D is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Ibuprofen US FDA 1
Metformin US FDA 1

Also appears on these molecule pages

Ibuprofen API Metformin API

Questions about Shijiazhuang Cready Pharmaceutical R And D

Does Shijiazhuang Cready Pharmaceutical R And D hold a US DMF or a CEP?
Shijiazhuang Cready Pharmaceutical R And D holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Shijiazhuang Cready Pharmaceutical R And D make?
2 molecules are on record against Shijiazhuang Cready Pharmaceutical R And D, including Ibuprofen and Metformin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shijiazhuang Cready Pharmaceutical R And D comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Solara Active Pharma Sciences shares 1 molecule Piramal Pharma shares 1 molecule SMS Pharmaceuticals shares 1 molecule Dipharma Francis shares 1 molecule Shandong Xinhua Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability